Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a cup of tea prevent pneumonia in ICU patients?

NCT ID NCT07688057

Prevention Sponsor: Recep Tayyip Erdogan University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 07, 2026 · Last updated Jul 09, 2026 · Updated 2 times

Summary

This study tests whether mouth care with green tea or white tea can prevent ventilator-associated pneumonia (VAP) as well as the standard antiseptic chlorhexidine. It includes adults in intensive care who are on breathing machines. The goal is to see if these natural alternatives reduce pneumonia rates while improving oral health.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
chlorhexidine, green tea, white tea
What this could lead to
If green or white tea proves as effective as chlorhexidine, it could offer a simpler, more natural option for preventing pneumonia in ventilated patients.
What could go wrong
This is a small study (63 patients) and results may not apply to all ICU settings. The teas might not prevent pneumonia as well as the standard antiseptic.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

63 people

The number who actually took part.

Started

Jan 2024

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Aged over 18 years 2. With no known allergies 3. Receiving invasive mechanical ventilator support 4. With a negative endotracheal aspirate culture on the day of ICU admission 5. Within the first 24 hours of mechanical ventilator support 6. Patients whose relatives agreed to participate in the study Exclusion Criteria: 1. Patients with positive endotracheal aspirate cultures within the first 48 hours of intensive care admission, 2. Patients undergoing radiotherapy or chemotherapy, 3. Patients with contraindications for oral care, 4. Patients with a platelet count below 30,000/mm³, 5. Patients who cannot be positioned appropriately, 6. Patients with agitation severe enough to prevent the procedure from being performed

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mechanical ventilation are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

nosocomial infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Mechanical ventilation Oral care Ventilation acquired pneumonia

Contacts and locations

Locations

  • Recep Tayyip Erdogan University Research and Training Hospital

    Rize, Merkez, 53020, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.